Tumor News and Research

RSS

New precision medicine treatment for bone cancer in dogs opens door for human clinical trials

In a first-of-its-kind study, scientists at the University of Missouri have helped advance a patient-specific, precision medicine treatment for bone cancer in dogs.

29 Jan 2019

EZH2 mutations can be used as marker for diagnosing different types of cancers

Inside the cell, DNA is tightly wrapped around proteins and packed in a complex, 3D structure that we call "chromatin".

29 Jan 2019

Review paper on transformative potential of precision and personalized medicine for cancer treatment

In a paper published in the September/December 2018 issue of TECHNOLOGY, a group of researchers from Rutgers University Department of Biomedicine Engineering have published a review paper on the transformative potential of precision and personalized medicine (PPM) for cancer treatment.

29 Jan 2019

GW researchers engineer nanoimmunotherapy to treat cancer

A team from the George Washington University Cancer Center has engineered a nanoimmunotherapy that combines the advantages of nanotechnology and immunotherapy to treat cancer.

28 Jan 2019

Researchers discover immune regulator that appears to dictate glioblastoma

Researchers at The University of Texas MD Anderson Cancer Center have discovered an immune regulator that appears to dictate glioblastoma progression by shutting down immune surveillance, indicating a potential new area of therapeutic investigation.

28 Jan 2019

Targeting Sirt-1 enzyme shows promise in controlling graft-vs-host disease

Bone marrow transplant offers patients with leukemia and lymphoma a potentially curative treatment. Bone marrow from the donor contains healthy immune cells, whose mission is to protect the body from invaders.

28 Jan 2019

Injection of genetically modified virus effectively treats metastatic melanoma patients

Injection of a genetically modified virus that induces the body's own immune cells to attack metastatic melanoma effectively treated almost 40 percent of patients with tumors that could not be surgically removed, according to researchers from three prominent cancer centers in a study published as an "article in press" on the Journal of the American College of Surgeons website in advance of print publication.

28 Jan 2019

Regular use of aspirin may help some patients survive head and neck cancer

Regular use of aspirin or other nonsteroidal anti-inflammatory drugs may help some patients with head and neck cancer survive the disease, according to a study led by Professor Jennifer Grandis at the University of California, San Francisco.

27 Jan 2019

Regular use of common pain relief medicines improves survival for head and neck cancer patients

Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found.

25 Jan 2019

Stratasys advanced FDM 3D printing helps Biodonostia to improve treatment for thoracic wall tumors

Founded in 2008, the Biodonostia Health Research Institute was the first institute for medical research in the Basque region of Spain. Facing difficult surgical challenges every day, it recently partnered with Tknika, a Research and Applied Innovation Centre for Vocational Education and Training in the Basque region, and Tecnun, a specialist division of Universidad de Navarra, to enable surgeons to harness the latest 3D printing technology as a tool to aid surgical preparedness.

From Stratasys 25 Jan 2019

Study suggests link between keloids and high risk of breast cancer among African Americans

Findings from a new study conducted by researchers at Henry Ford Health System suggest a link between keloids and increased risk of being diagnosed with breast cancer, particularly among African Americans

25 Jan 2019

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

The Damon Runyon Cancer Research Foundation announced that nine scientists with novel approaches to fighting cancer have been named 2019 recipients of the Damon Runyon-Rachleff Innovation Award.

24 Jan 2019

Novel therapeutic approach for treatment of leukemia

The BCR/ABL gene, which does not occur among healthy people, has been shown to be a causative agent in the pathogenesis of B-cell acute lymphocytic leukemia.

24 Jan 2019

Researchers identify marker protein that offers both diagnostic and therapeutic function

Of all gastrointestinal cancers, pancreatic cancer is one of the most aggressive. Because of this, it has a very low 5-year survival rate of just 5% and a median survival time below 6 months. Additionally, treatment is difficult, with only surgery shown to provide a cure. However, the vast majority of patients have tumors that cannot be removed surgically or their cancer is too advanced or spread too far to be treatable.

24 Jan 2019

Researchers reveal important signaling pathway in breast cancer

Researchers at Kanazawa University report in Proceedings of the National Academy of Sciences of the United States of America that a particular signaling pathway in breast-cancer tumors causes cancer cells to divide symmetrically, expanding the tumor. Inhibiting the pathway by drugs could become a strategy for eliminating the cancer cells.

24 Jan 2019

Tumor News and Research

New precision medicine treatment for bone cancer in dogs opens door for human clinical trials

EZH2 mutations can be used as marker for diagnosing different types of cancers

Review paper on transformative potential of precision and personalized medicine for cancer treatment

GW researchers engineer nanoimmunotherapy to treat cancer

Researchers discover immune regulator that appears to dictate glioblastoma

Targeting Sirt-1 enzyme shows promise in controlling graft-vs-host disease

Injection of genetically modified virus effectively treats metastatic melanoma patients

Regular use of aspirin may help some patients survive head and neck cancer

Regular use of common pain relief medicines improves survival for head and neck cancer patients

Stratasys advanced FDM 3D printing helps Biodonostia to improve treatment for thoracic wall tumors

Study suggests link between keloids and high risk of breast cancer among African Americans

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

Novel therapeutic approach for treatment of leukemia

Researchers identify marker protein that offers both diagnostic and therapeutic function

Researchers reveal important signaling pathway in breast cancer

Cellular recycling process may prevent cancer initiation, finds study

Transmissible cancer in Tasmanian devils unlikely to cause extinction, study reveals

Lab-Scale Clarification of Mammalian Cell Cultures Expressing Recombinant Antibodies

Top institutions in the U.S. win Cancer Research UK's Grand Challenge competition

Ludwig researchers find ways to make resistant melanomas susceptible to immunotherapy

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News